Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Hedgehog Inhibition for Pancreatic Ductal Adenocarcinoma (PDAC) in the Preoperative Setting (HIPPoS) (HIPPoS)

This study has been terminated.
(Slow recruitment)
Sponsor:
Collaborators:
Roche Pharma AG
Genentech, Inc.
Information provided by (Responsible Party):
Lisa Bax, Cambridge University Hospitals NHS Foundation Trust
ClinicalTrials.gov Identifier:
NCT01096732
First received: March 30, 2010
Last updated: January 7, 2014
Last verified: January 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: August 2012
  Primary Completion Date: August 2012 (Final data collection date for primary outcome measure)